Delivery Order SPE2DB20D1100-SPE2DB25FC7L3
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix 1 unit/mL syringes valued at $14,927.65 on May 27, 2025, with a completion date of May 28, 2025. This is a firm fixed-price, non-set-aside contract with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Havrix is a hepatitis A vaccine commonly used in military and federal healthcare settings to maintain disease prevention across the armed forces and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,666.37 firm fixed price delivery order for 1,440 units of HAVRIX 1,440 Unit/mL syringe on April 18, 2025, with ultimate completion scheduled for April 21, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania headquarters. HAVRIX is a hepatitis A vaccine commonly utilized by the Department of Defense for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Havrix 1,440 unit/mL syringes, with a ceiling value of $5,837.03 and a firm fixed price structure. This is a competitively awarded, non-set-aside contract with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Havrix is a hepatitis A vaccine commonly used in military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on August 19, 2025, with ultimate completion by August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems for disease prevention and immunization...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/milliliter of HAVRIX vaccine delivered via syringe. This firm fixed price, non-set-aside contract was awarded on July 15, 2025, with an ultimate completion date of July 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine used to support immunization requirements across the Department...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,440 units of HAVRIX 1,440 Unit/mL syringes valued at $1,931.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A...
- The Defense Logistics Agency awarded a delivery order valued at $1,613.80 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 4, 2025, and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the location of performance for this delivery order, which falls under the company's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems to support troop...